BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 23982111)

  • 21. Duration of vasomotor symptoms in middle-aged women: a longitudinal study.
    Col NF; Guthrie JR; Politi M; Dennerstein L
    Menopause; 2009; 16(3):453-7. PubMed ID: 19188852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vasomotor symptoms usually reappear after cessation of postmenopausal hormone therapy: a Swedish population-based study.
    Lindh-Astrand L; Brynhildsen J; Hoffman M; Hammar M
    Menopause; 2009; 16(6):1213-7. PubMed ID: 19455070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes of the prescription of hormone therapy in menopausal women: an observational study in Taiwan.
    Huang WF; Tsai YW; Hsiao FY; Liu WC
    BMC Public Health; 2007 Apr; 7():56. PubMed ID: 17439639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patterns and predictors of sexual activity among women in the Hormone Therapy trials of the Women's Health Initiative.
    Gass ML; Cochrane BB; Larson JC; Manson JE; Barnabei VM; Brzyski RG; Lane DS; LaValleur J; Ockene JK; Mouton CP; Barad DH
    Menopause; 2011 Nov; 18(11):1160-71. PubMed ID: 21983008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Symptoms reported by women in midlife: menopausal transition or aging?
    Berecki-Gisolf J; Begum N; Dobson AJ
    Menopause; 2009; 16(5):1021-9. PubMed ID: 19546824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of TCM acupuncture on hot flushes among menopausal women (ACUFLASH) study: a study protocol of an ongoing multi-centre randomised controlled clinical trial.
    Borud EK; Alraek T; White A; Fonnebo V; Grimsgaard S
    BMC Complement Altern Med; 2007 Feb; 7():6. PubMed ID: 17324253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Duration not severity of the climacteric syndrome predicts resumption of hormone therapy after discontinuation: a prospective cohort study.
    Haimov-Kochman R; Barak-Glantz E; Ein-Mor E; Arbel R; Brzezinski A; Milwidsky A; Hochner-Celnikier D
    Hum Reprod; 2006 Sep; 21(9):2450-4. PubMed ID: 16731546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors associated with use of hormone therapy among women with mobility impairments.
    Yang K; Becker H; Dormire S
    Women Health; 2006; 43(1):19-36. PubMed ID: 17050483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Understanding the menopausal experiences of professional women.
    Simon JA; Reape KZ
    Menopause; 2009; 16(1):73-6. PubMed ID: 18779760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid loss of hip fracture protection after estrogen cessation: evidence from the National Osteoporosis Risk Assessment.
    Yates J; Barrett-Connor E; Barlas S; Chen YT; Miller PD; Siris ES
    Obstet Gynecol; 2004 Mar; 103(3):440-6. PubMed ID: 14990403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. After the Women's Health Initiative: decision making and trust of women taking hormone therapy.
    Schonberg MA; Davis RB; Wee CC
    Womens Health Issues; 2005; 15(4):187-95. PubMed ID: 16051110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Health-related quality of life of women with menopausal hot flushes and night sweats.
    Ayers B; Hunter MS
    Climacteric; 2013 Apr; 16(2):235-9. PubMed ID: 22809134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors for night sweats and hot flushes in midlife: results from a prospective cohort study.
    Herber-Gast GC; Mishra GD; van der Schouw YT; Brown WJ; Dobson AJ
    Menopause; 2013 Sep; 20(9):953-9. PubMed ID: 23531688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trends in middle-aged women's reports of symptoms, use of hormone therapy and attitudes towards it.
    Ekström H
    Maturitas; 2005 Oct; 52(2):154-64. PubMed ID: 16186078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trends in hormone therapy use before and after publication of the Women's Health Initiative trial: 10 years of follow-up.
    Barbaglia G; Macià F; Comas M; Sala M; del Mar Vernet M; Casamitjana M; Castells X
    Menopause; 2009; 16(5):1061-4. PubMed ID: 19369903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. After the Women's Health Initiative: Postmenopausal women's experiences with discontinuing estrogen replacement therapy.
    Haskell SG
    J Womens Health (Larchmt); 2004 May; 13(4):438-42. PubMed ID: 15186661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patterns of hormone therapy use in the Norwegian Women and Cancer study (NOWAC) 1996-2005.
    Waaseth M; Bakken K; Lund E
    Maturitas; 2009 Jul; 63(3):220-6. PubMed ID: 19394168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severity of menopausal symptoms of Jordanian women.
    Gharaibeh M; Al-Obeisat S; Hattab J
    Climacteric; 2010 Aug; 13(4):385-94. PubMed ID: 19731118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Persistent hot flushes in older postmenopausal women.
    Huang AJ; Grady D; Jacoby VL; Blackwell TL; Bauer DC; Sawaya GF
    Arch Intern Med; 2008 Apr; 168(8):840-6. PubMed ID: 18443259
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Health care-seeking for menopausal problems.
    Guthrie JR; Dennerstein L; Taffe JR; Donnelly V
    Climacteric; 2003 Jun; 6(2):112-7. PubMed ID: 12841881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.